HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 45649,
"recordsTotal": 45649,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=-sponsor__name&start=45300",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=-sponsor__name&start=44700",
"results": [
{
"registry_id": "NCT06315322",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06315322",
"title": "A MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE LONG-TERM SAFETY AND TOLERABILITY OF BRIVARACETAM IN STUDY PARTICIPANTS WITH CHILDHOOD ABSENCE EPILEPSY OR JUVENILE ABSENCE EPILEPSY",
"has_exemption": false,
"start_date": "2024-07-10",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06532123",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06532123",
"title": "Mechanisms of Improving Fecal Continence Muscles Motor Function in Health and Disease",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06965114",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06965114",
"title": "A Phase 1b Study of Combination Tovorafenib (DAY101) and Rituximab Treatment in Relapsed or Refractory Classical Hairy Cell Leukemia and Phase 2 Randomized Study Comparing Tovorafenib (DAY101) and Rituximab With Cladribine and Rituximab for Front-Line Treatment of Classical Hairy Cell Leukemia",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04200729",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04200729",
"title": "Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis",
"has_exemption": false,
"start_date": "2027-03-01",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05952557",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05952557",
"title": "CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease",
"has_exemption": false,
"start_date": "2023-10-05",
"completion_date": "2030-03-04",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06899126",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06899126",
"title": "A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan in Combination With Pembrolizumab Versus Platinum-based Chemotherapy in Combination With Pembrolizumab, as First-line Therapy in Participants With Locally Advanced Unresectable or Metastatic HER2 Overexpressing and PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer (DESTINY-Lung06)",
"has_exemption": false,
"start_date": "2025-09-07",
"completion_date": "2030-03-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03148418",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03148418",
"title": "An Open-Label, Multicenter Extension and Long-Term Observational Study in Patients Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study",
"has_exemption": false,
"start_date": "2017-09-20",
"completion_date": "2030-03-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06869551",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06869551",
"title": "A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Children and Adolescents From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2025-03-13",
"completion_date": "2030-03-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05837897",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05837897",
"title": "A Phase 3, Multicenter, Randomized, Parallel-Group, Double-blind, Placebo-Controlled Induction Study Followed by an Open-label Extension Period to Evaluate the Efficacy and Safety of Intravenous Vedolizumab (300 mg) Infusion Treatment in Subjects in China With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2023-06-16",
"completion_date": "2030-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05432791",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05432791",
"title": "A Randomized Phase 2/3 Study of Olaparib Plus Temozolomide Versus Investigator's Choice for the Treatment of Patients With Advanced Uterine Leiomyosarcoma After Progression on Prior Chemotherapy",
"has_exemption": false,
"start_date": "2023-03-30",
"completion_date": "2030-03-09",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05785767",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05785767",
"title": "A Randomized, Double-Blind Phase 2/3 Study of Fianlimab (Anti-LAG-3 Antibody) in Combination With Cemiplimab (Anti-PD-1 Antibody) Versus Cemiplimab Monotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Tumors Expressing PD-L1 ≥50%",
"has_exemption": false,
"start_date": "2023-06-30",
"completion_date": "2030-03-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05646381",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05646381",
"title": "A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis [Lp(a)FRONTIERS CAVS]",
"has_exemption": false,
"start_date": "2024-03-07",
"completion_date": "2030-03-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05691478",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05691478",
"title": "A Feasibility and Randomized Phase 2/3 Study of the VEGFR2/MET Inhibitor Cabozantinib in Combination With Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma",
"has_exemption": false,
"start_date": "2023-03-03",
"completion_date": "2030-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06347055",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06347055",
"title": "Neuronavigated Non-invasive Brain Stimulation for Nicotine Dependence.",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2030-03-25",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Missouri-Columbia",
"sponsor_slug": "university-of-missouri-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06856577",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06856577",
"title": "A Multi-Center, Randomized, Double-Masked, Active-Comparator-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration (ARTEMIS)",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2030-03-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Adverum Biotechnologies, Inc.",
"sponsor_slug": "adverum-biotechnologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05352919",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05352919",
"title": "A Multicenter, Randomized, Dose-Blind, Phase 3 Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus",
"has_exemption": false,
"start_date": "2022-06-10",
"completion_date": "2030-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06439693",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06439693",
"title": "A Single-Arm, Phase II Study of Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer: The SAPPHO Study",
"has_exemption": false,
"start_date": "2024-08-08",
"completion_date": "2030-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02050113",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02050113",
"title": "Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices",
"has_exemption": false,
"start_date": "2014-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Andres Schanzer",
"sponsor_slug": "andres-schanzer",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03048201",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03048201",
"title": "Post-market Registry Study on the Physica System Total Knee Replacement",
"has_exemption": false,
"start_date": "2017-03-24",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Limacorporate S.p.a",
"sponsor_slug": "limacorporate-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03674372",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03674372",
"title": "Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Right and Left Congenital Diaphragmatic Hernia (CDH)",
"has_exemption": false,
"start_date": "2018-11-16",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03959085",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03959085",
"title": "A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy",
"has_exemption": false,
"start_date": "2019-10-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04683250",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04683250",
"title": "Phase I/II Study of the Selective RET Inhibitor TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene Abnormalities",
"has_exemption": false,
"start_date": "2020-12-16",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Taiho Pharmaceutical Co., Ltd.",
"sponsor_slug": "taiho-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06153173",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06153173",
"title": "A Phase II Trial of the MEK Inhibitor Mirdametinib in Histiocytic Disorders",
"has_exemption": false,
"start_date": "2024-02-05",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06117774",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06117774",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Have Not Progressed Following Concurrent Chemoradiation Therapy",
"has_exemption": false,
"start_date": "2024-02-20",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06013865",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06013865",
"title": "An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)",
"has_exemption": false,
"start_date": "2024-04-05",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06424756",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06424756",
"title": "Role of Mitochondria-derived Oxidative Stress on Microvascular Endothelial Function in Healthy Non-Hispanic Black and White Adults",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Georgia",
"sponsor_slug": "university-of-georgia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06510374",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06510374",
"title": "A Phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ferring Pharmaceuticals",
"sponsor_slug": "ferring-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06802315",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06802315",
"title": "A Phase II Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Myeloablative Fludarabine/Busulfan and Post-Transplant Cyclophosphamide (PTCY) for Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk AML, CML, and MDS",
"has_exemption": false,
"start_date": "2025-02-04",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06322576",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06322576",
"title": "A Phase 2, Single-Arm, Multi-center Study of 177Lu-PSMA (177Lu-PNT2002) in Patients With PSMA-Positive Adenoid Cystic Carcinoma",
"has_exemption": false,
"start_date": "2025-02-10",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926790",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06926790",
"title": "Neoadjuvant Nivolumab Plus Ipilimumab in Resectable Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The First Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "the-first-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06805305",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06805305",
"title": "Randomized Study of DOC1021 Dendritic Cell Immunotherapy in Combination With Standard of Care for Newly Diagnosed Adult Glioblastoma",
"has_exemption": false,
"start_date": "2025-03-17",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Diakonos Oncology Corporation",
"sponsor_slug": "diakonos-oncology-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06881823",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06881823",
"title": "NeoPSMA: A Phase I/II, Open-label, Multi-center Study of Neoadjuvant Treatment With [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Adults With Prostate-specific Membrane Antigen (PSMA) Positive High-risk Localized Prostate Cancer (HRLPC) Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847269",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06847269",
"title": "CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia: An Investigation of Lymphodepleting Chemotherapy Pharmacokinetics",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06937866",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06937866",
"title": "Maintenance Zanzalintinib With Oral Etoposide Following High-dose Chemotherapy in Patients With Relapsed Metastatic Germ-cell Tumor",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096297",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07096297",
"title": "A Phase II Study of Luspatercept Plus Darbepoetin Alfa in SF3B1 Wild Type Lower-risk Myelodysplastic Syndromes",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04387305",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04387305",
"title": "Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): an Efficacy Study",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Daniel Nishijima, MD, MAS",
"sponsor_slug": "daniel-nishijima-md-mas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04042402",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04042402",
"title": "An Open-Label Roll-Over Study to Evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injection (Subcutaneous Use) in Patients With Primary Hyperoxaluria",
"has_exemption": false,
"start_date": "2019-07-09",
"completion_date": "2030-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dicerna Pharmaceuticals, Inc., a Novo Nordisk company",
"sponsor_slug": "dicerna-pharmaceuticals-inc-a-novo-nordisk-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029776",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07029776",
"title": "A Phase 2 Study Exploring the Use of Bispecific Antibodies to Improve Progression Free Survival in Patients With High-Risk Newly Diagnosed Multiple Myeloma (MMulti-Immune HR)",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arkansas",
"sponsor_slug": "university-of-arkansas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04303169",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04303169",
"title": "A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02C",
"has_exemption": false,
"start_date": "2020-06-26",
"completion_date": "2030-04-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04305041",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04305041",
"title": "A Phase 1/2 Open-label Rolling-arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02A",
"has_exemption": false,
"start_date": "2020-06-26",
"completion_date": "2030-04-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04305054",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04305054",
"title": "A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02B",
"has_exemption": false,
"start_date": "2020-07-01",
"completion_date": "2030-04-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04700072",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04700072",
"title": "A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02D",
"has_exemption": false,
"start_date": "2021-05-03",
"completion_date": "2030-04-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03718403",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03718403",
"title": "Effect of Theophylline in Pseudohypoparathyroidism",
"has_exemption": false,
"start_date": "2019-11-11",
"completion_date": "2030-04-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05582993",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05582993",
"title": "A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis With Vonicog Alfa (rVWF) in Children Diagnosed With Severe Von Willebrand Disease",
"has_exemption": false,
"start_date": "2024-11-06",
"completion_date": "2030-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06632977",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06632977",
"title": "PREcision DIagnostics in Prostate Cancer Treatment (PREDICT)",
"has_exemption": false,
"start_date": "2025-02-06",
"completion_date": "2030-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07061574",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07061574",
"title": "A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2030-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06397703",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06397703",
"title": "A Phase II Prospective 2-Arm Cohort Interventional Trial Utilizing Ultra-Hypofractionated SBRT With or Without Short Course Androgen Deprivation Therapy For Unfavorable Intermediate Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2024-04-16",
"completion_date": "2030-04-16",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06742723",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06742723",
"title": "A Phase III, Randomised, Double-blind, Placebo-controlled, Event-driven Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on Renal Outcomes and Cardiovascular Mortality in Participants With Chronic Kidney Disease and High Blood Pressure",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2030-04-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06133972",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06133972",
"title": "A Randomized, Double-blind, Placebo-controlled Extension Study to Assess the Long-term Safety and Tolerability of Ianalumab in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE Extension)",
"has_exemption": false,
"start_date": "2024-05-21",
"completion_date": "2030-04-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01817517",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01817517",
"title": "Phase 1 Study of Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome",
"has_exemption": false,
"start_date": "2014-03-31",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04408625",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04408625",
"title": "A Phase 1/2 Ascending Dose Study to Evaluate the Safety and Effects on Progranulin Levels of LY3884963 in Patients With Fronto-Temporal Dementia With Progranulin Mutations (FTD-GRN)",
"has_exemption": false,
"start_date": "2020-11-09",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Prevail Therapeutics",
"sponsor_slug": "prevail-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04806854",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04806854",
"title": "A Single-Center, Randomized, Open-Label, Parallel Arm Study of Daily Oral LUM-201 in Naive-to-Treatment, Prepubertal Children With Idiopathic Pediatric Growth Hormone Deficiency (PGHD)",
"has_exemption": false,
"start_date": "2021-07-14",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lumos Pharma",
"sponsor_slug": "lumos-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05795595",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05795595",
"title": "A Phase 1/2, Open-label, Multicenter, Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD70 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX131) in Adult Subjects With Relapsed or Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2023-03-13",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CRISPR Therapeutics AG",
"sponsor_slug": "crispr-therapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06322108",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06322108",
"title": "Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)",
"has_exemption": false,
"start_date": "2024-06-13",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Immune Oncology Research Institute",
"sponsor_slug": "immune-oncology-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05919108",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05919108",
"title": "Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt-Ingram Cancer Center",
"sponsor_slug": "vanderbilt-ingram-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05829460",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05829460",
"title": "Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia",
"has_exemption": false,
"start_date": "2025-03-12",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06721689",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06721689",
"title": "A Phase 1/2 Clinical Trial of the Novel Topoisomerase I Inhibitor PEEL-224 as a Single Agent and in Combination With Vincristine and Temozolomide in Children With Refractory, Progressive or Relapsed Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-23",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Theodore Laetsch",
"sponsor_slug": "theodore-laetsch",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06666348",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06666348",
"title": "A Phase 1/2 Study of Mirdametinib and Vinblastine for Newly Diagnosed or Previously Untreated Patients With Pediatric Low-grade Glioma and Activation of the MAPK Pathway",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "C17 Council",
"sponsor_slug": "c17-council",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06884423",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06884423",
"title": "Infant Survival and Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial",
"has_exemption": false,
"start_date": "2025-04-07",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Holly L Hedrick, MD",
"sponsor_slug": "holly-l-hedrick-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06892678",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06892678",
"title": "DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma",
"has_exemption": false,
"start_date": "2025-04-07",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Montefiore Medical Center",
"sponsor_slug": "montefiore-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06702033",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06702033",
"title": "Phase II Trial of Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: \"The Minimalist Trial-2 (MINT-2)\"",
"has_exemption": false,
"start_date": "2025-04-10",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06861920",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06861920",
"title": "Targeting Interindividual Variability in NSAID Responses to Mitigate Chronic Pelvic Pain Risk in Dysmenorrhea",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Endeavor Health",
"sponsor_slug": "endeavor-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06946576",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06946576",
"title": "Infant Survival and Long-term Outcomes Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Oregon Health and Science University",
"sponsor_slug": "oregon-health-and-science-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03346694",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03346694",
"title": "Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing",
"has_exemption": false,
"start_date": "2018-05-01",
"completion_date": "2030-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06585410",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06585410",
"title": "A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC)",
"has_exemption": false,
"start_date": "2025-01-02",
"completion_date": "2030-05-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05692180",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05692180",
"title": "Efficacy and Safety of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)",
"has_exemption": false,
"start_date": "2023-04-05",
"completion_date": "2030-05-05",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06663722",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06663722",
"title": "A Phase II b Study of Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease",
"has_exemption": false,
"start_date": "2025-05-05",
"completion_date": "2030-05-05",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04821310",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04821310",
"title": "AN EXPLORATORY, MULTICENTER, RANDOMIZED, DOUBLE BLIND STUDY OF CLINICAL OUTCOMES, TOLERABILITY, AND SAFETY OF 2 DOSES OF ORAL PANTOPRAZOLE IN PEDIATRIC PARTICIPANTS AGED 1 TO 11 YEARS AND 12 TO 17 YEARS WHO REQUIRE MAINTENANCE THERAPY FOR HEALED EROSIVE ESOPHAGITIS",
"has_exemption": false,
"start_date": "2022-01-13",
"completion_date": "2030-05-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05061550",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05061550",
"title": "A Phase II, Open-label, Multicentre, Randomised Study of Neoadjuvant and Adjuvant Treatment in Patients With Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer (NeoCOAST-2)",
"has_exemption": false,
"start_date": "2022-04-14",
"completion_date": "2030-05-09",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06841354",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06841354",
"title": "A Phase 3, Randomized, Open-label Study Comparing Efficacy and Safety of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as a Monotherapy and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With Previously Untreated Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Expressing PD-L1 at CPS Less Than 10 (TroFuse-011)",
"has_exemption": false,
"start_date": "2025-03-16",
"completion_date": "2030-05-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06932757",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06932757",
"title": "Phase 2 Trial of Adjuvant Quisinostat in High-Risk Uveal Melanoma",
"has_exemption": false,
"start_date": "2025-05-27",
"completion_date": "2030-05-27",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07052903",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07052903",
"title": "TRITON-CM: A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2030-05-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Alnylam Pharmaceuticals",
"sponsor_slug": "alnylam-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05775367",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05775367",
"title": "Cochlear Implantation in Infants and Toddlers With Single-Sided Deafness",
"has_exemption": false,
"start_date": "2023-07-07",
"completion_date": "2030-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02115295",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02115295",
"title": "Phase II Study of Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With AML, HR MDS, or Myeloid Blast Phase of CML",
"has_exemption": false,
"start_date": "2014-05-19",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02310399",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02310399",
"title": "Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves",
"has_exemption": false,
"start_date": "2014-05-31",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03618186",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03618186",
"title": "Neuroimaging Study",
"has_exemption": false,
"start_date": "2018-11-26",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03821857",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03821857",
"title": "Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease",
"has_exemption": false,
"start_date": "2019-06-27",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05951179",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05951179",
"title": "A Phase 2, Open-Label Study to Evaluate the Safety and Anti-Tumor Activity of Intravesical Instillation of TARA-002 in Adults With High-Grade Non-Muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2023-09-15",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Protara Therapeutics",
"sponsor_slug": "protara-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06492304",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06492304",
"title": "A Phase 1/2 Dose Evaluation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD70 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX131) in Adult Subjects With Relapsed/Refractory Hematologic Malignancies",
"has_exemption": false,
"start_date": "2024-08-13",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CRISPR Therapeutics",
"sponsor_slug": "crispr-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06851338",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06851338",
"title": "Pediatric Down Syndrome Post-Approval Study",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Inspire Medical Systems, Inc.",
"sponsor_slug": "inspire-medical-systems-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07010692",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07010692",
"title": "Using Fractional Lasers and Tirbanibulin Ointment to Treat Keratinocyte Carcinomas",
"has_exemption": false,
"start_date": "2025-05-16",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bruce Robinson, MD",
"sponsor_slug": "bruce-robinson-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06876662",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06876662",
"title": "Long-Term Safety of Pirtobrutinib in Participants From Study LOXO-BTK-18001 With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06876649",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06876649",
"title": "A Master Protocol to Evaluate the Long-Term Safety of Pirtobrutinib",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961955",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06961955",
"title": "FAST NOVEMBER: A Phase II Randomized Trial of a 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029828",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07029828",
"title": "A LONG-TERM, DOUBLE-BLIND EXTENSION STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF RITLECITINIB IN PARTICIPANTS WITH SEVERE ALOPECIA AREATA WHO PREVIOUSLY COMPLETED STUDIES B7981027 OR B7981031",
"has_exemption": false,
"start_date": "2025-07-14",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06814496",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06814496",
"title": "RAdiation comBined With BIspecific T-Cell Engager in DLL3 Expressing Tumors (RABBIT) Study: A Phase I/II Study of AMG757 / Tarlatamab and Concurrent Radiation Therapy in Tumors With High Prevalence of DLL3",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07097363",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07097363",
"title": "A Pilot Study of Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for Upfront Treatment of Aggressive B-Cell Non-Hodgkin Lymphomas",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07087938",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07087938",
"title": "Safety and Behavioral Pharmacology of Cannabichromene as an Adjunct to Rheumatoid Arthritis Treatment; Effects on Inflammatory Markers and Rheumatoid Arthritis Disease Activity",
"has_exemption": false,
"start_date": "2028-07-15",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Crystal Lederhos Smith",
"sponsor_slug": "crystal-lederhos-smith",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04900623",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04900623",
"title": "Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study",
"has_exemption": false,
"start_date": "2021-07-02",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonathan Schoenfeld, MD, MPH",
"sponsor_slug": "jonathan-schoenfeld-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06872333",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06872333",
"title": "Allogeneic Hematopoietic Stem Cell Transplant for Patients With High Risk Hemoglobinopathies and Other Red Cell Transfusion Dependent Disorders",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06810778",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06810778",
"title": "Phase I/II Study of Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)",
"has_exemption": false,
"start_date": "2025-05-02",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06800092",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06800092",
"title": "Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment",
"has_exemption": false,
"start_date": "2025-06-15",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Medical Branch, Galveston",
"sponsor_slug": "the-university-of-texas-medical-branch-galveston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07060066",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07060066",
"title": "Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04007276",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04007276",
"title": "The Effect of Lumify™ (Brimonidine Tartrate Ophthalmic Solution 0.025%) on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients Using Brimonidine 0.2%, 0.15%, or 0.1%",
"has_exemption": false,
"start_date": "2025-11-10",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Tulane University",
"sponsor_slug": "tulane-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04457076",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04457076",
"title": "A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate LevoCept™, a Long-Acting Reversible Intrauterine System for Contraceptive Efficacy, Safety, and Tolerability",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sebela Women's Health Inc.",
"sponsor_slug": "sebela-womens-health-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05998408",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05998408",
"title": "A Phase I/II Study of the JAK1/2 Inhibitor Ruxolitinib for Relapsed / Refractory Immune Bone Marrow Failure",
"has_exemption": false,
"start_date": "2024-02-20",
"completion_date": "2030-06-03",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07019454",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07019454",
"title": "Baystate Health Physician Sponsored - Investigational Device Exception: Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2030-06-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Baystate Medical Center",
"sponsor_slug": "baystate-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06995508",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06995508",
"title": "Managing Anorexia During Chemoradiation With Olanzapine (MACRO)",
"has_exemption": false,
"start_date": "2025-09-13",
"completion_date": "2030-06-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06077760",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06077760",
"title": "A Phase 3, Randomized, Double-blind, Placebo- and Active-Comparator-Controlled Clinical Study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With Resected Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer (INTerpath-002)",
"has_exemption": false,
"start_date": "2023-12-06",
"completion_date": "2030-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05335876",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05335876",
"title": "Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 IT or OAV101 IV in Clinical Trials",
"has_exemption": false,
"start_date": "2022-12-19",
"completion_date": "2030-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06578247",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06578247",
"title": "Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial Of Quizartinib Administered in Combination With Induction and Consolidation Chemotherapy and Administered as Maintenance Therapy in Adult Patients With Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2030-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04004169",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04004169",
"title": "Closed-Loop Deep Brain Stimulation for Treatment-Resistant Depression",
"has_exemption": false,
"start_date": "2019-07-18",
"completion_date": "2030-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Andrew Krystal",
"sponsor_slug": "andrew-krystal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05161195",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05161195",
"title": "A Post-trial Access Roll-over Study to Allow Access to Ribociclib (LEE011) for Patients Who Are on Ribociclib Treatment in Novartis-sponsored Study",
"has_exemption": false,
"start_date": "2022-07-07",
"completion_date": "2030-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06994845",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06994845",
"title": "A Single-arm, Multicenter, Phase III Study to Assess Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients of 2 to <18 Years of Age With Primary Immunoglobulin A Nephropathy (IgAN)",
"has_exemption": false,
"start_date": "2025-12-08",
"completion_date": "2030-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03971669",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03971669",
"title": "Collection of Blood Samples for In-Vitro Studies from Healthy Adult Blood Donors Who Have Received Oral Typhoid Vaccine (TY21A)",
"has_exemption": false,
"start_date": "2004-01-16",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03547973",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03547973",
"title": "A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer",
"has_exemption": false,
"start_date": "2018-08-13",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04305145",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04305145",
"title": "Phase II Study of Infliximab for the Treatment of Immune Checkpoint Inhibitor Colitis",
"has_exemption": false,
"start_date": "2020-08-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05422222",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05422222",
"title": "A Phase 3 Study Evaluating the Pharmacokinetics, Safety, and Tolerability of VX-121/Tezacaftor/Deutivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 1 Through 11 Years of Age",
"has_exemption": false,
"start_date": "2022-06-21",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06118892",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06118892",
"title": "Post-Market Evaluation of the MISHA® Knee System for Symptom Relief in Subjects With Medial Knee Osteoarthritis",
"has_exemption": false,
"start_date": "2023-11-03",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Moximed",
"sponsor_slug": "moximed",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384573",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06384573",
"title": "The Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Amyloid Removal Trial (ART): A Phase IIIb/IV Open-Label Study of Lecanemab to Evaluate Prevention and Progression of Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2024-06-10",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06122974",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06122974",
"title": "A RanDomized Controlled Trial of the Drug Eluting TEmporary Spur StEnt System vs PERcutaneous Balloon Angioplasty for the TReatment of CriTical Limb Ischemia",
"has_exemption": false,
"start_date": "2024-06-30",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ReFlow Medical, Inc.",
"sponsor_slug": "reflow-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06131502",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06131502",
"title": "ExAblate MR-guided Focused Ultrasound Bilateral Anterior Capsulotomy for Treatment of Obsessive-Compulsive Disorder",
"has_exemption": false,
"start_date": "2024-10-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06904313",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06904313",
"title": "Evaluation of Ultralow Dose PET Imaging for Detecting PSMA Expression",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akiva Mintz",
"sponsor_slug": "akiva-mintz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06956391",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06956391",
"title": "Evaluation of Ultralow Dose PET Imaging for Detecting 18F-FDG Uptake",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akiva Mintz",
"sponsor_slug": "akiva-mintz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07012993",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07012993",
"title": "Evaluation of Ultralow Dose PET Imaging for Detecting Amyloid Tracer Uptake",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akiva Mintz",
"sponsor_slug": "akiva-mintz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07038343",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07038343",
"title": "A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-06-19",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Avenzo Therapeutics, Inc.",
"sponsor_slug": "avenzo-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06464926",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06464926",
"title": "A Prospective Randomized Controlled Trial of Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Enterra Medical, Inc.",
"sponsor_slug": "enterra-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953089",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06953089",
"title": "A Phase II, Multicenter, Open-Label Trial of DB-1311 in Combination With BNT327 or DB-1305 in Participants With Advanced/Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "DualityBio Inc.",
"sponsor_slug": "dualitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06474273",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06474273",
"title": "A Multicenter Randomized Controlled Trial to Treat Acute t Cell Mediated Rejection in Kidney and Kidney-pancreas Transplant Recipients",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Sydney",
"sponsor_slug": "university-of-sydney",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07076342",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07076342",
"title": "Mechanistic Clinical Trial Evaluating the Role of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5) in the Antidepressant Mechanism of Cognitive Behavioral Therapy for Insomnia (CBT-I)",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stony Brook University",
"sponsor_slug": "stony-brook-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07067463",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07067463",
"title": "A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Primary Progressive Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Beijing InnoCare Pharma Tech Co., Ltd.",
"sponsor_slug": "beijing-innocare-pharma-tech-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06520098",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06520098",
"title": "Benefit of Venetoclax Addition (\"Benefit VA\") in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07084441",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07084441",
"title": "Comparison of Outcomes of Management of Bowel Obstruction",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699966",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06699966",
"title": "Stony Brook Medicine Anti-Inflammatory Trial",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stony Brook University",
"sponsor_slug": "stony-brook-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04814082",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04814082",
"title": "Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot",
"has_exemption": false,
"start_date": "2021-02-01",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "LifeBridge Health",
"sponsor_slug": "lifebridge-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05564377",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05564377",
"title": "Molecular Analysis for Combination Therapy Choice (ComboMATCH)",
"has_exemption": false,
"start_date": "2023-04-07",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961071",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06961071",
"title": "Parathyroid Allotransplant for Treatment of Hypoparathyroidism: PATTH",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Peter Stock",
"sponsor_slug": "peter-stock",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525389",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06525389",
"title": "Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04715646",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04715646",
"title": "Open-Label, Single-Arm, Multicenter Study to Evaluate Long-Term Safety and Tolerability of Brivaracetam Used as Adjunctive Treatment in Pediatric Study Participants With Epilepsy",
"has_exemption": false,
"start_date": "2021-03-11",
"completion_date": "2030-07-08",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04684602",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04684602",
"title": "Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions",
"has_exemption": false,
"start_date": "2020-07-09",
"completion_date": "2030-07-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Advanced Medical LLC",
"sponsor_slug": "thomas-advanced-medical-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07064460",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07064460",
"title": "Duke Customized Aortic Aneurysm Repair With Endovascular Stent-grafts - Duke CARES Trial",
"has_exemption": false,
"start_date": "2025-07-11",
"completion_date": "2030-07-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Chandler Long, MD",
"sponsor_slug": "chandler-long-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07089901",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07089901",
"title": "Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2030-07-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06054230",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06054230",
"title": "Genomic Sequencing for Evaluation of Fetal Structural Anomalies",
"has_exemption": false,
"start_date": "2023-09-18",
"completion_date": "2030-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06678737",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06678737",
"title": "CBIT+TMS R33 Phase",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2030-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979596",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06979596",
"title": "A Multicenter, Open-label, Phase 2 Basket Study of MK-5684 in Participants With Selected Solid Tumors (OMAHA-015)",
"has_exemption": false,
"start_date": "2025-07-17",
"completion_date": "2030-07-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06711887",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06711887",
"title": "An Open-label Extension Study to Assess the Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Adult Participants With Lupus Nephritis Who Have Completed Study Treatment in the CVAY736K12301 Core Study (SIRIUS-LN Extension)",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2030-07-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06321601",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06321601",
"title": "A Phase 3, Open-label, Uncontrolled Single-arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Avacopan in Combination With a Rituximab or a Cyclophosphamide-containing Regimen in Children From 6 Years to < 18 Years of Age With Active ANCA-associated Vasculitis (AAV)",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2030-07-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06022939",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06022939",
"title": "A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients With Newly Diagnosed AL Amyloidosis",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2030-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06561386",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06561386",
"title": "A Phase 3, Randomized, Open-label Study of Nivolumab + Relatlimab Fixed-dose Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy as First-line Treatment for Participants With Non-squamous (NSQ), Stage IV or Recurrent Non-small Cell Lung Cancer and With Tumor Cell PD-L1 Expression ≥ 1%",
"has_exemption": false,
"start_date": "2024-10-07",
"completion_date": "2030-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06731413",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06731413",
"title": "Phase 2 Study to Evaluate Reduced Dose Chemotherapy in Combination With Anti-PD-1 Therapy as First Line Treatment in Vulnerable or Older Adults (Vulnerable or Age ≥70) With Advanced PD-L1 TPS <50% Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2030-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06969755",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06969755",
"title": "Biomarkers to Enhance Early Schizophrenia Treatment",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2030-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06716866",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06716866",
"title": "Temporally Interfering Electric Field Stimulation in the Treatment of Epilepsy - Effect of Temporal Interference on Biomarkers of Epilepsy",
"has_exemption": false,
"start_date": "2019-01-16",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04743141",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04743141",
"title": "Phase 3, Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Rimegepant for the Acute Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to < 18 Years of Age",
"has_exemption": false,
"start_date": "2021-04-28",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05145127",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05145127",
"title": "AN OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF MARSTACIMAB PROPHYLAXIS IN SEVERE (COAGULATION FACTOR ACTIVITY <1%) HEMOPHILIA A PARTICIPANTS WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY ≤2%) WITH OR WITHOUT INHIBITORS",
"has_exemption": false,
"start_date": "2021-11-17",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05469893",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05469893",
"title": "Immuno-PRISM (PRecision Intervention Smoldering Myeloma): A Randomized Phase II Platform Study of Select Immunotherapies for High-Risk Smoldering Myeloma",
"has_exemption": false,
"start_date": "2022-08-10",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Irene Ghobrial, MD",
"sponsor_slug": "irene-ghobrial-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072131",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06072131",
"title": "A Phase 3, Randomized, Open-Label Study Comparing the Efficacy and Safety of the Combination of Beleodaq-CHOP or Folotyn-COP to the CHOP Regimen Alone in Newly Diagnosed Patients With Peripheral T-Cell Lymphoma",
"has_exemption": false,
"start_date": "2023-10-04",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Acrotech Biopharma Inc.",
"sponsor_slug": "acrotech-biopharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05821855",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05821855",
"title": "A Postmarketing Study Evaluating the Effectiveness and Safety of the XEN45 Glaucoma Treatment System in Subjects With Open-Angle Glaucoma in China",
"has_exemption": false,
"start_date": "2023-12-08",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06461897",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06461897",
"title": "A Phase 3, Open-label, Efficacy-Assessor-Blinded Study, Comparing the Safety and Efficacy of Upadacitinib to Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2024-08-19",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06577025",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06577025",
"title": "A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Different Sequences of Ciltacabtagene Autoleucel (Cilta-cel), Talquetamab SC in Combination With Daratumumab SC (Tal-D) and Teclistamab SC in Combination With Daratumumab SC (Tec-D) Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) in Participants With Standard-risk Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-08-20",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06992440",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06992440",
"title": "Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gustavo A Heresi, MD, MS",
"sponsor_slug": "gustavo-a-heresi-md-ms",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007273",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07007273",
"title": "Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06941857",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06941857",
"title": "A Phase 2 Study of NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Treatment-naïve, Metastatic Pancreatic Cancer",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06950385",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06950385",
"title": "A Phase 3, Multi-Site, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of eRapa to Improve Clinical Outcomes in Patients With Familial Adenomatous Polyposis",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rapamycin Holdings Inc.",
"sponsor_slug": "rapamycin-holdings-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029529",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07029529",
"title": "Phase 2 Dose-response Study of Apremilast in Women and Men With Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05737693",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05737693",
"title": "Posttraumatic Stress Disorder (PTSD) Treatment: Using Ketamine to Enhance Memory Reconsolidation and Extinction of Overgeneralized Fear in Individuals Diagnosed With PTSD",
"has_exemption": false,
"start_date": "2023-08-21",
"completion_date": "2030-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06467344",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06467344",
"title": "ACDN-01-001: Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Subretinal ACDN-01 in Participants With ABCA4-related Retinopathy",
"has_exemption": false,
"start_date": "2024-06-11",
"completion_date": "2030-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ascidian Therapeutics, Inc",
"sponsor_slug": "ascidian-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06843551",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06843551",
"title": "A Phase 2 Single Arm Trial of Stereotactic Body Radiation Therapy Followed by Dual Immune Checkpoint Inhibition for Patients With Metastatic Pancreatic Ductal Adenocarcinoma - The Miami \"EMPIRE\" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2030-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Benjamin Spieler",
"sponsor_slug": "benjamin-spieler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06902246",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06902246",
"title": "Regorafenib and Yttrium-90 Radioembolization for Treatment of Unresectable Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2030-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926595",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06926595",
"title": "Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) With Low-Dose Post-Transplant Cyclophosphamide for Prophylaxis of Graft-versus-Host Disease in Hematological Malignancies",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2030-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06997081",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06997081",
"title": "Elranatamab, Lenalidomide, Dexamethasone in Newly Diagnosed Multiple Myeloma, a Clinical and Correlative Phase 2 Study",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2030-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07002216",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07002216",
"title": "A Phase 2 Trial of Abbreviated Brentuximab Vedotin, Etoposide, Cyclophosphamide, Adriamycin, Dacarbazine, and Dexamethasone (BrECADD) Therapy in Stage 2 B-IV Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2030-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06942442",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06942442",
"title": "A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma",
"has_exemption": false,
"start_date": "2025-08-25",
"completion_date": "2030-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Alliance for Research through Collaboration",
"sponsor_slug": "sarcoma-alliance-for-research-through-collaboration",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976840",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06976840",
"title": "Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2030-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Marta Peciña MD PhD",
"sponsor_slug": "marta-pecina-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04579224",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04579224",
"title": "A Phase III Randomized Trial of Eribulin (NSC #707389) With Gemcitabine Versus Standard of Care (Physician's Choice) for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for, Anti PD1/PDL1 Therapy",
"has_exemption": false,
"start_date": "2021-06-28",
"completion_date": "2030-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06971939",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06971939",
"title": "A Phase 4, Multicenter, Open-label Study to Evaluate Long-term Safety and Efficacy of Revakinagene Taroretcel-Lwey (NT-501) Previously Implanted During a Phase 1, Phase 2, or Phase 3 Clinical Study and to Evaluate NT-501 Implanted in Participants Who Underwent the Sham Procedure in a Phase 3 Clinical Study of Macular Telangiectasia Type 2 (MacTel)",
"has_exemption": false,
"start_date": "2025-08-15",
"completion_date": "2030-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurotech Pharmaceuticals",
"sponsor_slug": "neurotech-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06651970",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06651970",
"title": "A Multicentre, Open-label, Randomised Phase IV Study to Investigate Acalabrutinib Monotherapy Compared to Investigator's Choice of Treatment in Adults (> 18 Years) With Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment",
"has_exemption": false,
"start_date": "2025-02-04",
"completion_date": "2030-08-16",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06683755",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06683755",
"title": "Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2030-08-16",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06910813",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06910813",
"title": "An Open-label, Multi-center, Phase I/II Study to Assess Safety, Tolerability and Efficacy of DFT383 in Pediatric Participants With Nephropathic Cystinosis",
"has_exemption": false,
"start_date": "2025-06-02",
"completion_date": "2030-08-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05983276",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05983276",
"title": "Combination of the Hypomethylating Agent Decitabine and the Nuclear Export Receptor XPO-1 Inhibitor Selinexor to Reverse Platinum Resistance in Relapsed/Refractory Epithelial Ovarian Cancer",
"has_exemption": false,
"start_date": "2023-11-16",
"completion_date": "2030-08-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Loyola University",
"sponsor_slug": "loyola-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04877522",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04877522",
"title": "An Open Label, Multi-center Asciminib Roll-over Study to Assess Long-term Safety in Patients Who Have Completed a Novartis Sponsored Asciminib Study and Are Judged by the Investigator to Benefit From Continued Treatment",
"has_exemption": false,
"start_date": "2022-08-30",
"completion_date": "2030-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05451004",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05451004",
"title": "SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer. A Phase III Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2023-02-10",
"completion_date": "2030-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Canadian Cancer Trials Group",
"sponsor_slug": "canadian-cancer-trials-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07039422",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07039422",
"title": "Exploratory Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab (VAY RE-HIT)",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2030-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07079111",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07079111",
"title": "3D Printed Occlusal Splints for Intraoperative Use",
"has_exemption": false,
"start_date": "2025-08-30",
"completion_date": "2030-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06051617",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06051617",
"title": "AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis",
"has_exemption": false,
"start_date": "2023-09-07",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07008469",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07008469",
"title": "A Global Phase 3 Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Intravenous AOC 1001 for the Treatment of Myotonic Dystrophy Type 1",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avidity Biosciences, Inc.",
"sponsor_slug": "avidity-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948019",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06948019",
"title": "Safety and Efficacy of AAV9/AP4B1 For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47): A Phase 1/2 Single-Center, Open-Label Study of Stereotactic Intra-cisterna Magna Administration",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BlackfinBio Ltd",
"sponsor_slug": "blackfinbio-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06963905",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06963905",
"title": "Phase Ib Randomized Open-label Trial of Sacituzumab Govitecan Plus Nivolumab or Sacituzumab Govitecan Plus Nivolumab and Relatlimab as Second-line Therapy for PD-L1 Positive Metastatic Triple Negative Breast Cancer",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07022405",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07022405",
"title": "Stratified Pharmacological Approaches for Regulating Circuit-Level Effects Study",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06813014",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06813014",
"title": "Sitagliptin's Effects on Glucose-stimulated Insulin Secretion and Oral Glucose",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06841679",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06841679",
"title": "A Multi-national, Open-label, Randomized Phase II/III Clinical Study of Utidelone Capsule (UTD2) Combined with Capecitabine and Oxaliplatin in First-line Treatment of Patients with PD-L1-negative Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Beijing Biostar Pharmaceuticals Co., Ltd.",
"sponsor_slug": "beijing-biostar-pharmaceuticals-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06827990",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06827990",
"title": "Evaluation of the GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07043738",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07043738",
"title": "Imaging- vs. Scalp-Targeted Accelerated TMS for Depression: The Number Needed to Scan Trial",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06794944",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06794944",
"title": "Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients with Inflammatory Bowel Disease",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05987241",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05987241",
"title": "MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer",
"has_exemption": false,
"start_date": "2024-02-02",
"completion_date": "2030-09-02",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780085",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06780085",
"title": "KEYMAKER-U01 Substudy 01H: A Phase 2, Randomized, Umbrella Study With Rolling Arms of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-05-13",
"completion_date": "2030-09-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06784752",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06784752",
"title": "A Phase III Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients Newly Diagnosed With Grade 1 and Grade 2 (Ki-67 <10%) Advanced GEP-NET With High Disease Burden (NETTER-3)",
"has_exemption": false,
"start_date": "2025-05-30",
"completion_date": "2030-09-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02559778",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02559778",
"title": "A Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by a Randomized Controlled Trial of Standard Immunotherapy With or Without DFMO Followed by DFMO Maintenance for Subjects With Newly Diagnosed High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2015-09-30",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03143374",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03143374",
"title": "Positron Emission Tomography (PET) Imaging of Tau Pathology in Neurodegenerative Disease",
"has_exemption": false,
"start_date": "2016-09-30",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04584853",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04584853",
"title": "PreOperative Endocrine Therapy for Individualised Care With Abemaciclib",
"has_exemption": false,
"start_date": "2020-12-23",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Institute of Cancer Research, United Kingdom",
"sponsor_slug": "institute-of-cancer-research-united-kingdom",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04685616",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04685616",
"title": "A Randomised Phase III Trial With a PET Response Adapted Design Comparing ABVD +/- ISRT With A2VD +/- ISRT in Patients With Previously Untreated Stage IA/IIA Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2022-04-14",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University College, London",
"sponsor_slug": "university-college-london",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06109272",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06109272",
"title": "A Phase 2/3, Randomized Study to Evaluate the Dose Optimization, Safety, and Efficacy of Livmoniplimab in Combination With Budigalimab in Subjects With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) Who Have Not Previously Received Systemic Treatment",
"has_exemption": false,
"start_date": "2024-01-11",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06441955",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06441955",
"title": "Covid-19 Long Haul Syndrome: Undiagnosed Disorder Post Covid-19 Alternative Treatment Study.",
"has_exemption": false,
"start_date": "2024-03-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Well- Konnect Healthcare Services and Research Firm",
"sponsor_slug": "well-konnect-healthcare-services-and-research-firm",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05673018",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05673018",
"title": "REACH Study: Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity",
"has_exemption": false,
"start_date": "2024-07-12",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "GRAIL, Inc.",
"sponsor_slug": "grail-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06475989",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06475989",
"title": "A Randomized Phase III Study of BRAF-Targeted Therapy vs Cabozantinib in RAI-Refractory Differentiated Thyroid Cancer With BRAF V600Em",
"has_exemption": false,
"start_date": "2024-08-22",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06518785",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06518785",
"title": "Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-01-07",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06417190",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06417190",
"title": "IIT2023-13-BALLAS-VHTMT: Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Leslie Ballas",
"sponsor_slug": "leslie-ballas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06861244",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06861244",
"title": "PNOC031: Protocol for Embryonal Tumor With Multilayered Rosettes (ETMR)",
"has_exemption": false,
"start_date": "2025-03-06",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06639607",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06639607",
"title": "Phase 1/2 Trial of PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma (PRiME II)",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953882",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06953882",
"title": "SELECT: A Phase II Adjuvant Trial Evaluating the Impact of Omitting Chemotherapy Based on Patient's Selection for Moderate to High-Anatomical Risk, Low-Genomic Risk, ER-Positive, HER2- Negative Breast Cancer With a Combination Regimen of Ribociclib and Optimized Endocrine Therapy",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06966362",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06966362",
"title": "Varenicline for Smoking Reduction in Veterans Unwilling to Quit",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06919939",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06919939",
"title": "Phase 2 Study of Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07075510",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07075510",
"title": "A Phase I/II Study of Subcutaneous Daratumumab Administration in the Anterior Upper Thigh Vs Abdomen in Patients With Plasma Cell Disorders",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096362",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07096362",
"title": "A Phase 2 Study Assessing Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05487599",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05487599",
"title": "An Open-label, Dose-Finding, Phase 1/2 Study to Evaluate the Safety and Tolerability of a Single Intravenous Dose of LY3884961 in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)",
"has_exemption": false,
"start_date": "2022-12-20",
"completion_date": "2030-10-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Prevail Therapeutics",
"sponsor_slug": "prevail-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04270409",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04270409",
"title": "A Phase 3 Randomized, Open-label, Multicenter Study of Isatuximab (SAR650984) in Combination With Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With High-risk Smoldering Multiple Myeloma",
"has_exemption": false,
"start_date": "2020-06-16",
"completion_date": "2030-10-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525766",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06525766",
"title": "Single Arm Pilot Trial of Adaptive Therapy (AT) With Capecitabine for the Treatment of Metastatic Estrogen Receptor Positive, Hormone Refractory Breast Cancer",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2030-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04725110",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04725110",
"title": "Phase II Trial of Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 ARDS - A Multi-Site, Randomized, Double-blinded, Placebo-Controlled Clinical Trial",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2030-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03516617",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03516617",
"title": "Randomized Phase 2 Study Comparing Acalabrutinib to Acalabrutinib and Obinutuzumab in the Treatment of Patients With Early-Stage Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Who Are at High Risk of Disease Progression",
"has_exemption": false,
"start_date": "2018-09-10",
"completion_date": "2030-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06669117",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06669117",
"title": "A First-In-Human (FIH) Phase I/II Open-label, Multicentre, Dose Escalation and Expansion Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors Including Non-small Cell Lung Cancer (NSCLC) Harboring Mesenchymal-Epithelial Transition (MET) Alterations",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2030-10-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Pierre Fabre Medicament",
"sponsor_slug": "pierre-fabre-medicament",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04545957",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04545957",
"title": "Judging MR Simulation Procedures: A Phase I-II Study of the Use of Magnetic Resonance Imaging Simulation in the Planning of Radiation Treatments",
"has_exemption": false,
"start_date": "2020-10-14",
"completion_date": "2030-10-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06646289",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06646289",
"title": "An Open-label, Multicenter, Phase 2 Follow-on Study for Second Eye Treatment of Patients Previously Treated With a Recombinant Adeno-associated Virus Vector (AAV5 hRKp.RPGR) for Gene Therapy of Adults and Children With X-linked Retinitis Pigmentosa Owing to Defects in Retinitis Pigmentosa GTPase Regulator (RPGR)",
"has_exemption": false,
"start_date": "2024-10-10",
"completion_date": "2030-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04062266",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04062266",
"title": "Phase II Study of 5-Azacytidine (AZA) + Venetoclax as Maintenance Therapy in Patients With AML in Remission",
"has_exemption": false,
"start_date": "2019-09-13",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04948619",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04948619",
"title": "Immune Function and Response to Vaccination Following Completion of Cancer Directed Systemic Therapy in Pediatric Patients With Cancer",
"has_exemption": false,
"start_date": "2022-08-08",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05371093",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05371093",
"title": "A Phase 3 Randomized, Open-Label, Multicenter Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects With Relapsed/Refractory Follicular Lymphoma",
"has_exemption": false,
"start_date": "2022-09-12",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kite, A Gilead Company",
"sponsor_slug": "kite-a-gilead-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05933395",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05933395",
"title": "Genetically-informed Therapy for ER+ Breast Cancer in a Post-CDK4/6 Inhibitor Setting: a Phase II Umbrella Study (GERTRUDE)",
"has_exemption": false,
"start_date": "2023-10-10",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dartmouth-Hitchcock Medical Center",
"sponsor_slug": "dartmouth-hitchcock-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06121180",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06121180",
"title": "A Phase II Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2024-11-04",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06628310",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06628310",
"title": "A Phase 2 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of ABBV-400 in Combination With Fluorouracil, Leucovorin, and Budigalimab as First-Line Treatment in Subjects With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (AndroMETa-GEA-977)",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06541262",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06541262",
"title": "Phase I/II Study of Silmitasertib (CX-4945) in Combination With Chemotherapy in Children and Young Adults With Relapsed Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2024-10-30",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06906887",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06906887",
"title": "PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer",
"has_exemption": false,
"start_date": "2025-06-17",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06934655",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06934655",
"title": "Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Los Angeles",
"sponsor_slug": "childrens-hospital-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03750227",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03750227",
"title": "Pre-Operative vs. Post-Operative Stereotactic Radiosurgery for Operative Metastatic Brain Tumors",
"has_exemption": false,
"start_date": "2018-11-19",
"completion_date": "2030-11-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07050186",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07050186",
"title": "A Single Arm Open-Label Pilot Study to Investigate the Safety and Clinical Activity of Cemiplimab, A Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients With Incurable NUT Carcinoma (NC)",
"has_exemption": false,
"start_date": "2025-11-20",
"completion_date": "2030-11-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05295290",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05295290",
"title": "Low Interventional Cohort Study of Myocarditis/Pericarditis Associated With COMIRNATY in Persons Less Than 21 Years of Age",
"has_exemption": false,
"start_date": "2022-11-21",
"completion_date": "2030-11-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06128070",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06128070",
"title": "Phase 2a Study of Adding Ruxolitinib With Tacrolimus/Methotrexate Regimen for Graft-versus-Host Disease Prophylaxis in Myeloablative Conditioning Hematopoietic Cell Transplantation in Pediatric and Young Adult Patients",
"has_exemption": false,
"start_date": "2024-07-16",
"completion_date": "2030-11-22",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06211764",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06211764",
"title": "A Phase 3, Randomized, Open-label, Multi-center Study Evaluating the Efficacy and Safety of TAR-200 Versus Investigator's Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High-risk Non-muscle-invasive Bladder Cancer (HR-NMIBC) and Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy",
"has_exemption": false,
"start_date": "2024-04-09",
"completion_date": "2030-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03587272",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03587272",
"title": "Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2018-04-17",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Robert Nickel",
"sponsor_slug": "robert-nickel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04157985",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04157985",
"title": "Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2019-11-15",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jason J. Luke, MD",
"sponsor_slug": "jason-j-luke-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04927416",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04927416",
"title": "The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer",
"has_exemption": false,
"start_date": "2021-10-25",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05967351",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05967351",
"title": "A Phase 3, Multinational, Long-term Follow-up Study to Evaluate Safety and Efficacy in Subjects Who Have Previously Received SRP-9001 in a Clinical Study",
"has_exemption": false,
"start_date": "2023-09-27",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarepta Therapeutics, Inc.",
"sponsor_slug": "sarepta-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06185673",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06185673",
"title": "A Phase 1b/2a, Open-label, Dose Escalation Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia",
"has_exemption": false,
"start_date": "2023-11-28",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Benitec Biopharma, Inc.",
"sponsor_slug": "benitec-biopharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06169371",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06169371",
"title": "Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)",
"has_exemption": false,
"start_date": "2023-12-28",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06462547",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06462547",
"title": "The ADAPT Study: An Open-label, Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency",
"has_exemption": false,
"start_date": "2024-06-19",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Inozyme Pharma",
"sponsor_slug": "inozyme-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06608927",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06608927",
"title": "A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Arcus Biosciences, Inc.",
"sponsor_slug": "arcus-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06593093",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06593093",
"title": "A Bundled Intervention to End Opioid Overdose by Increasing Treatment Uptake Post Emergency Department Discharge",
"has_exemption": false,
"start_date": "2025-02-13",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649357",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06649357",
"title": "Comparison Between Bipolar Transurethral Resection of the Prostate and Moses Assisted Holmium Laser Enucleation of the Prostate. A Prospective Randomized Multicentric Study",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Fundacio Puigvert",
"sponsor_slug": "fundacio-puigvert",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06952686",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06952686",
"title": "A Seamless Phase 1/3, Multicenter, Single Dose Systemic Gene Transfer Study to Evaluate the Safety, Tolerability, and Efficacy of SRP-9005 in Limb Girdle Muscular Dystrophy Type 2C/R5 Subjects (COMPASS)",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarepta Therapeutics, Inc.",
"sponsor_slug": "sarepta-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06052956",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06052956",
"title": "A Phase 2 Study to Assess Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05863351",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05863351",
"title": "Phase III Randomized Trial of Stereotactic Ablative Radiotherapy (SAbR) for Oligometastatic Advanced Renal Carcinoma (SOAR)",
"has_exemption": false,
"start_date": "2023-09-07",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06569680",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06569680",
"title": "Phase II Trial of Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma (EMZL) (ML44933)",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Izidore Lossos, MD",
"sponsor_slug": "izidore-lossos-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06540963",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06540963",
"title": "Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2024-12-06",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06640491",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06640491",
"title": "Intraosseous Vancomycin and Cefazolin vs Intravenous Administration in Primary Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2025-05-15",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06124157",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06124157",
"title": "An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitors With Blinatumomab in Patients With Newly-Diagnosed Philadelphia Chromosome-Positive or ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2025-05-30",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05145309",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05145309",
"title": "Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans",
"has_exemption": false,
"start_date": "2025-11-15",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07022678",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07022678",
"title": "A Randomized Double-Blinded Trial of Xylitol Dental Wipes for the Prophylaxis of Bloodstream Infections From Oral Organisms in Pediatric Patients With Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2025-11-18",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007221",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07007221",
"title": "Clinical Trials to Evaluate Metformin to Treat Depression in People Living With HIV",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06136650",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06136650",
"title": "MK-5684-004: A Phase 3, Randomized, Open-label Study of Opevesostat Versus Alternative Abiraterone Acetate or Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed On or After Prior Treatment With One Next-generation Hormonal Agent (NHA) (OMAHA-004)",
"has_exemption": false,
"start_date": "2023-12-18",
"completion_date": "2030-12-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06923072",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06923072",
"title": "A Phase IIa Trial of Baricitinib in the Treatment of Kohlmeier-Degos Disease Patients With Neurological Involvement",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2030-12-14",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03769415",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03769415",
"title": "HARMONY: Harnessing the Analysis of RNA Expression and Molecular Subtype to Optimize Novel TherapY for Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2018-11-06",
"completion_date": "2030-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05253131",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05253131",
"title": "A Phase 1/2 Trial of the MEK Inhibitor Selumetinib and Bromodomain Inhibitor With Durvalumab (MEDI4736), a PD-L1 Antibody for Sarcomas Including Malignant Peripheral Nerve Sheath Tumors (NF112)",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2030-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06393374",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06393374",
"title": "A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice (TPC) in Participants With Triple-Negative Breast Cancer (TNBC) Who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response (pCR) at Surgery",
"has_exemption": false,
"start_date": "2024-06-24",
"completion_date": "2030-12-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679101",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06679101",
"title": "A Phase 3, Randomized, Open-label Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)",
"has_exemption": false,
"start_date": "2024-12-27",
"completion_date": "2030-12-23",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04877288",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04877288",
"title": "A Prospective, Open-label, Multicenter, Randomized Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Renal Allograft Recipients Aged 12 to Less Than 18 Years of Age to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications",
"has_exemption": false,
"start_date": "2021-07-21",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05431088",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05431088",
"title": "A Phase 2/3 Randomized, Multicenter Study of Osivelotor Administered Orally to Participants With Sickle Cell Disease and an Open-Label Pharmacokinetics Study in Pediatric Participants With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2022-09-22",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06482801",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06482801",
"title": "Intra-tumor Delivery of Double Checkpoint Inhibitors, Chemodrug, and/or Bevacizumab Therapy as First Line for Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2024-06-10",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06619509",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06619509",
"title": "A Phase II, Single-arm, Open-label, Long-term Safety Rollover Trial of Oral Brigimadlin in Patients With Solid Tumours",
"has_exemption": false,
"start_date": "2024-12-30",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06332807",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06332807",
"title": "An Open-Label, Multiple-Center, Phase I/II Dose Escalation Study for the Safety and Efficacy of NGGT002 in Adults With Classic Phenylketonuria",
"has_exemption": false,
"start_date": "2025-01-10",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NGGT INC.",
"sponsor_slug": "nggt-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06941272",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06941272",
"title": "LIGHTBEAM-U01 Substudy 01C: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2025-05-26",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06701760",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06701760",
"title": "Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01042379",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01042379",
"title": "I-SPY Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)",
"has_exemption": false,
"start_date": "2010-03-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "QuantumLeap Healthcare Collaborative",
"sponsor_slug": "quantumleap-healthcare-collaborative",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03915015",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03915015",
"title": "VAPORHCS/OHSU J: Safety of Clinically Indicated Magnetic Resonance Imaging in Patients With Permanent Pacemakers (PPM) and Implanted Cardioverter Defibrillators (ICDs)",
"has_exemption": false,
"start_date": "2012-07-19",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Oregon Health and Science University",
"sponsor_slug": "oregon-health-and-science-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01746836",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01746836",
"title": "Ponatinib as Second Line Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib, Dasatinib or Nilotinib",
"has_exemption": false,
"start_date": "2013-01-17",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02128906",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02128906",
"title": "A Randomized, Phase II Study of Definitive Radiotherapy With Concurrent Cisplatin vs. Docetaxel-cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma: an ERCC1 Biomarker Enrichment and Interaction Design",
"has_exemption": false,
"start_date": "2013-12-23",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Christopher Wilke",
"sponsor_slug": "christopher-wilke",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02019706",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02019706",
"title": "Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome",
"has_exemption": false,
"start_date": "2014-02-12",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03868150",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03868150",
"title": "Assessment of Intra-Operative Atrial Fibrillation Inducibility As a Screening Tool to Prevent Post-Operative Atrial Fibrillation With Prophylaxis Amiodarone",
"has_exemption": false,
"start_date": "2017-03-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03138161",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03138161",
"title": "SAINT: A Phase 1/2 Study of Safe Amounts of IPLIMUMAB, NIVOLUMAB and TRABECTEDIN for Previously Treated Advanced Soft Tissue Sarcoma (STS)",
"has_exemption": false,
"start_date": "2017-04-13",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Oncology Research Center, LLC",
"sponsor_slug": "sarcoma-oncology-research-center-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03886311",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03886311",
"title": "The TNT Protocol: A Phase 2 Study Using Talimogene Laherparepvec,Nivolumab and Trabectedin as First, Second/Third Line Therapy for Advanced Sarcoma, Including Desmoid Tumor and Chordoma",
"has_exemption": false,
"start_date": "2019-05-15",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Oncology Research Center, LLC",
"sponsor_slug": "sarcoma-oncology-research-center-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04038346",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04038346",
"title": "Symptomatic Management of Lyme Arthritis",
"has_exemption": false,
"start_date": "2019-10-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Desiree Neville, MD",
"sponsor_slug": "desiree-neville-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04127578",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04127578",
"title": "A Phase 1/2a Open-Label Ascending Dose Study to Evaluate the Safety and Effects of LY3884961 in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)",
"has_exemption": false,
"start_date": "2020-01-03",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prevail Therapeutics",
"sponsor_slug": "prevail-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03871257",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03871257",
"title": "A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)",
"has_exemption": false,
"start_date": "2020-01-15",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04106466",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04106466",
"title": "Deep Brain Stimulation (DBS) for Treatment Resistant Depression: Exploration of Local Field Potentials (LFPs) With the Medtronic Summit RC+S \"Brain Radio\" System",
"has_exemption": false,
"start_date": "2020-01-21",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Helen Mayberg, MD",
"sponsor_slug": "helen-mayberg-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04166409",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04166409",
"title": "A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine Versus Selumetinib (NSC# 748727) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) Not Associated With BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)",
"has_exemption": false,
"start_date": "2020-01-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04614103",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04614103",
"title": "A Phase 2 Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (TIL or LN-145) in Patients With Metastatic Non-Small-Cell Lung Cancer",
"has_exemption": false,
"start_date": "2021-05-07",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04777071",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04777071",
"title": "68Ga-PSMA-11 PET in Patients With Prostate Cancer",
"has_exemption": false,
"start_date": "2021-05-17",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04844606",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04844606",
"title": "A Master Protocol for a Phase 3, Multicenter, Open-label, Long-term Extension Study to Evaluate the Long-term Efficacy and Safety of Mirikizumab in Children and Adolescents With Moderate-to-severe Ulcerative Colitis or Crohn's Disease",
"has_exemption": false,
"start_date": "2021-05-26",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07056348",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07056348",
"title": "Chronic Stimulation of the Motor Ventral Thalamus (VOP/VIM) for Motor Control in Humans",
"has_exemption": false,
"start_date": "2022-05-10",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pittsburgh",
"sponsor_slug": "university-of-pittsburgh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06654180",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06654180",
"title": "A Comparison of Myopia Control Efficacy in Children With Orthokeratology, Defocus Incorporated Multiple Segment (DIMS) Spectacles, Defocus Incorporated Soft Contact (DISK) Lenses, and Single-vision Spectacles for 12 Months",
"has_exemption": false,
"start_date": "2022-10-21",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kaikai QIU",
"sponsor_slug": "kaikai-qiu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05344833",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05344833",
"title": "Post-Autologous Transplant Maintenance with Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma",
"has_exemption": false,
"start_date": "2023-01-05",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05685238",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05685238",
"title": "Open-label, Long-term Safety and Efficacy Study of Mim8 in Participants With Haemophilia A With or Without Inhibitors",
"has_exemption": false,
"start_date": "2023-02-13",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05910528",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05910528",
"title": "A Phase 2, Multicenter, Double-blind, Two-arm Study of Subcutaneous RO7790121 for the Treatment of Subjects With Moderate to Severe Active Crohn's Disease",
"has_exemption": false,
"start_date": "2023-07-24",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06225596",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06225596",
"title": "A Randomized Open-Label Phase 2/3 Study of BT8009 as Monotherapy or in Combination in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)",
"has_exemption": false,
"start_date": "2024-01-24",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BicycleTx Limited",
"sponsor_slug": "bicycletx-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06134167",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06134167",
"title": "A Prospective, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Effectiveness of the Transdermal Compress Device in Participants With Transfemoral Amputations",
"has_exemption": false,
"start_date": "2024-06-11",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Balmoral Medical company",
"sponsor_slug": "balmoral-medical-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06381180",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06381180",
"title": "Wayne Warrior CAnnabis Research and Education: Cannabis and Behavioral Health",
"has_exemption": false,
"start_date": "2024-09-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wayne State University",
"sponsor_slug": "wayne-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06877312",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06877312",
"title": "Longitudinal Study to Investigate Different Treatment Protocols of Transcranial Electrical Stimulation for Individuals with Dementia",
"has_exemption": false,
"start_date": "2024-10-09",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Manitoba",
"sponsor_slug": "university-of-manitoba",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05409118",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05409118",
"title": "JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization",
"has_exemption": false,
"start_date": "2024-12-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Endologix",
"sponsor_slug": "endologix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06645106",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06645106",
"title": "Offering Routine and Rapid Point of Care (POC) Syphilis Testing in Pregnant Patients Presenting to the Emergency Department",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06713616",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06713616",
"title": "Comparative Effectiveness of Racemic Ketamine Versus Esketamine (Spravato®) for Depression",
"has_exemption": false,
"start_date": "2025-01-27",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06657794",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06657794",
"title": "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Cleveland Clinic",
"sponsor_slug": "the-cleveland-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06837857",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06837857",
"title": "Imaging, Cognition, and Opioids in Older Adults With Chronic Pain (I-COAP) Trial",
"has_exemption": false,
"start_date": "2025-04-16",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06960707",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06960707",
"title": "Prospective Randomized Trial of Two Versus One Week Accelerated Radiotherapy (PRATO)",
"has_exemption": false,
"start_date": "2025-04-29",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06655051",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06655051",
"title": "Efficacy and Safety of Single Plastic Stent Compared With Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancreatitis: A Single Center，Prospective，Non-inferiority, Open Label, Randomized, Controlled Trial",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Changhai Hospital",
"sponsor_slug": "changhai-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07050043",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07050043",
"title": "A Phase III RCT Comparing Low Dose Immunotherapy (Nivolumab) Combined With Standard Chemotherapy vs Standard Chemotherapy as First-line Treatment in Patients With Locally Advanced or Metastatic NSCLC",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dr Arvindran A/L Alaga",
"sponsor_slug": "dr-arvindran-al-alaga",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06568549",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06568549",
"title": "Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf® Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.",
"has_exemption": false,
"start_date": "2025-06-13",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953960",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06953960",
"title": "A Phase 1/2, Open-Label, Platform Study to Evaluate Safety and Efficacy of the BCL-2 Inhibitor ABBV-453 Given as Monotherapy or in Combination With Antimyeloma Regimens in Subjects With Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06934356",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06934356",
"title": "Shared Subcortical Arousal Systems Across Perceptual Modalities",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07079631",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07079631",
"title": "A Phase I/II, Randomized, Multi-site Trial to Investigate the Efficacy and Safety of BNT314 in Combination With BNT327 and Chemotherapy in Participants With Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07091396",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07091396",
"title": "Enhancing Functional Recovery With Home-based Transcranial Direct Current Stimulation (tDCS) in Patients With Stroke, Neurodegeneration and Brain Tumors",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07026461",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07026461",
"title": "Right-sided 1-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) Versus Left-sided Intermittent Theta Burst Stimulation (iTBS) in Patients With Depression. -a Randomized Non-inferiority Trial",
"has_exemption": false,
"start_date": "2025-09-15",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Region Örebro County",
"sponsor_slug": "region-orebro-county",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07061977",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07061977",
"title": "NRG-GY037: A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab Versus Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer",
"has_exemption": false,
"start_date": "2025-09-19",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06683534",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06683534",
"title": "Use of Quercetin to Increase Resiliency to Palmitic Acid in the Human Microvasculature",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06996730",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06996730",
"title": "A Double-Blind, Placebo-Controlled, Double-Dummy Study of Donanemab and RG6289 in PSEN1 E280A Mutation Carriers, and in Non-Randomized, Placebo-Treated Non-Carriers From the Same Kindred, to Evaluate the Efficacy and Safety of Donanemab, RG6289, or the Combination of Donanemab and RG6289, in the Treatment of Autosomal-Dominant Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Banner Health",
"sponsor_slug": "banner-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}